34715352|t|Memantine improves cognitive deficits via KATP channel inhibition in olfactory bulbectomized mice.
34715352|a|Patients with Alzheimer's disease (AD) demonstrate severely impaired olfactory systems, which occur in the early stages of the disease. Olfactory bulbectomy (OBX) in mice elicits cognitive deficits, and reduces cholinergic activity in the hippocampus. Here, we confirmed that the novel AD drug memantine rescues cognitive deficits via ATP-sensitive potassium (KATP) channel inhibition in OBX mice. Repeated memantine administration at 1-3 mg/kg p.o. for 14 days starting at 10 days after OBX surgery significantly rescued cognitive deficits in OBX mice, as assessed using Y-maze, novel object recognition, and passive avoidance tasks. Consistent with the rescued cognitive deficits in OBX mice, long-term potentiation (LTP) in the hippocampal cornu ammonis (CA) 1 region was markedly restored with memantine administration. As demonstrated by immunoblotting, the reductions of calcium/calmodulin-dependent protein kinase II (CaMKII) alpha (Thr-286) autophosphorylation and calcium/calmodulin-dependent protein kinase IV (CaMKIV; Thr-196) phosphorylation in the CA1 region of OBX mice were significantly restored with memantine. Conversely, pre-treatment with pinacidil, a KATP channel opener, failed to reinstate hippocampal LTP and CaMKII/CaMKIV activities in the CA1 region. Finally, improvement of cognitive deficits by memantine treatments was observed in OBX-operated Kir6.1 heterozygous (+/-) mice but not in OBX-operated Kir6.2 heterozygous (+/-) mice. Overall, our study demonstrates that memantine rescues OBX-induced cognitive deficits via Kir6.2 channel inhibition in the CA1 region.
34715352	0	9	Memantine	Chemical	MESH:D008559
34715352	19	37	cognitive deficits	Disease	MESH:D003072
34715352	93	97	mice	Species	10090
34715352	99	107	Patients	Species	9606
34715352	113	132	Alzheimer's disease	Disease	MESH:D000544
34715352	134	136	AD	Disease	MESH:D000544
34715352	257	260	OBX	Chemical	-
34715352	265	269	mice	Species	10090
34715352	278	296	cognitive deficits	Disease	MESH:D003072
34715352	385	387	AD	Disease	MESH:D000544
34715352	393	402	memantine	Chemical	MESH:D008559
34715352	411	429	cognitive deficits	Disease	MESH:D003072
34715352	487	490	OBX	Chemical	-
34715352	491	495	mice	Species	10090
34715352	506	515	memantine	Chemical	MESH:D008559
34715352	587	590	OBX	Disease	
34715352	621	639	cognitive deficits	Disease	MESH:D003072
34715352	643	646	OBX	Chemical	-
34715352	647	651	mice	Species	10090
34715352	762	780	cognitive deficits	Disease	MESH:D003072
34715352	784	787	OBX	Chemical	-
34715352	788	792	mice	Species	10090
34715352	897	906	memantine	Chemical	MESH:D008559
34715352	1072	1118	calcium/calmodulin-dependent protein kinase IV	Gene	12326
34715352	1120	1126	CaMKIV	Gene	12326
34715352	1174	1177	OBX	Disease	
34715352	1178	1182	mice	Species	10090
34715352	1216	1225	memantine	Chemical	MESH:D008559
34715352	1258	1267	pinacidil	Chemical	MESH:D020110
34715352	1339	1345	CaMKIV	Gene	12326
34715352	1400	1418	cognitive deficits	Disease	MESH:D003072
34715352	1422	1431	memantine	Chemical	MESH:D008559
34715352	1459	1462	OBX	Chemical	-
34715352	1472	1478	Kir6.1	Gene	16523
34715352	1498	1502	mice	Species	10090
34715352	1514	1517	OBX	Chemical	-
34715352	1527	1533	Kir6.2	Gene	16514
34715352	1553	1557	mice	Species	10090
34715352	1596	1605	memantine	Chemical	MESH:D008559
34715352	1614	1617	OBX	Chemical	-
34715352	1626	1644	cognitive deficits	Disease	MESH:D003072
34715352	1649	1655	Kir6.2	Gene	16514
34715352	Negative_Correlation	MESH:D008559	16514
34715352	Negative_Correlation	MESH:D008559	MESH:D000544
34715352	Negative_Correlation	MESH:D008559	MESH:D003072
34715352	Positive_Correlation	MESH:D008559	12326

